USPTO serial 76286486
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Toronto, Ontario, CA
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey L. Van Hoosear, Esq.
JEFFREY L VAN HOOSEAR KNOBBE, MARTENS, OLSON & BEAR LL.2040 MAIN ST 14TH FLIRVINE, CA 92614UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | CYTOLOGY PREPARATIONS FOR USE IN LABORATORY PROCEDURES FOR SCIENTIFIC USE | ACTIVE | — |
| 009 | CYTOLOGY ANALYSIS SYSTEM COMPRISED OF FILTRATION, STAINING, CENTRIFUGATION, DISAGGREGATION, PIPETTING, AND DEPOSITION APPARATUS; COMPUTER HARDWARE AND SOFTWARE FOR IDENTIFICATION OF CELL TYPES, EVALUATION OF CELL PREDISPOSITION TO DISEASE OR PRESENCE OF DISEASE BY MORPHOLOGICAL ANALYSIS OR ANALYSIS OF BIOCHEMICAL STAIN UPTAKE INCLUDING, IMMUNOLOGICAL AND IN SITU HYBRIDIZATION METHODS; SPECIMEN PREPARATION SYSTEM COMPRISED OF FILTRATION, STAINING, CENTRIFUGATION, DISAGGREGATION, PIPETTING, AND DEPOSITION APPARATUS FOR SCIENTIFIC USE; AUTOMATED MICROSCOPESK SPECIMEN PREPARATION SYSTEM FEATURING FILTRATION, STAINING, CENTRIFUGATION, DISAGGREGATION, PIPETTING, AND DEPOSITION APPARATUS FOR SCIENTIFIC USE; COMPUTER SOFTWARE FOR USE IN DATA CAPTURING AND STORAGE; INTEGRATED CYTOLOGY ANALYSIS SYSTEM COMPRISED OF SPECIMEN PREPARATION SYSTEMS COMPRISED OF FILTRATION, STAINING, CENTRIFUGATION, DISAGGREGATION, PIPETTING, AND DEPOSITION APPARATUS, IMAGE CAPTURE AND ANALYSIS SYSTEMS FEATURING DIGITAL CAMERA, MASS STORAGE DEVICES, HIGH-SPEED COMPUTER HARDWARE AND ASSOCIATED HARDWARE; AUTOMATED MICROSCOPE SYSTEM, NAMELY, A COMPUTER-CONTROLLED MICROSCOPE FOR THE AUTOMATED ANALYSIS | ACTIVE | — |
| 010 | MEDICAL DIAGNOSTIC EQUIPMENT, NAMELY, SYSTEMS COMPRISED OF FILTRATION, STAINING, CENTRIFUGATION, DIAGREGATION, PIPETTING, AND DEPOSITION APPARATUS EMPLOYING FLUID HANDLING AND MATERIAL DEPOSITION, CHEMICAL AND BIOCHEMICAL STAINING OF SPECIMEN, IMAGE PROCESSING, RECOGNITION AND ANALYSIS METHODOLOGIES WHICH ARE USED IN THE DIAGNOSTIC SCREENING AND ANALYSIS OF MEDICAL SAMPLES AND SPECIMENS | ACTIVE | — |
| 040 | CUSTOM MANUFACTURE OF MEDICAL DIAGNOSTIC EQUIPMENT FOR THE SCREENING AND ANALYSIS OF MEDICAL SAMPLES AND SPECIMENS | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 8, 2003 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 27, 2002 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Oct 24, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 6, 2002 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 23, 2002 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Mar 14, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 14, 2002 | PAPER RECEIVED | — | |
| Sep 10, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 31, 2001 | DOCK | ASSIGNED TO EXAMINER | — |